COVID 19, Interventional Studies – Sponsors and Health Interventions

Interventional studies on COVID-19 are mainly sponsored by non-industry organizations. The industry has sponsored interventional studies only in the US, China and the UK so far which means the industry is not responsive in developing clinical trials.

Considering the majority of studies are from China, traditional Chinese medicines can be expected to be the most frequently used health intervention. Industry has mainly sponsored studies using immunomodulators.

The category called “other” has included: angiogenesis inhibitors, cytotoxic agents, hormone therapy, vasodilators, colony-stimulating factors, antihistamines, sedatives, anthelmintic drug, ozone therapy, nutrition with or without rehabilitation, supplements, pulmonary training, washed microbiota transplantation, cannabis, probiotics, humanistic care, tele-medicine and WeChat.